Download PDF
Semin Respir Crit Care Med 2015; 36(04): 609-615
DOI: 10.1055/s-0035-1555614
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Novel Endoscopic Approaches to Treating Chronic Obstructive Pulmonary Disease and Emphysema

D. Gompelmann
1   Department of Pneumology and Critical Care Medicine, Thoraxklinik at University of Heidelberg, Heidelberg, Germany
2   Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
,
R. Eberhardt
1   Department of Pneumology and Critical Care Medicine, Thoraxklinik at University of Heidelberg, Heidelberg, Germany
2   Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
,
F. J. F. Herth
1   Department of Pneumology and Critical Care Medicine, Thoraxklinik at University of Heidelberg, Heidelberg, Germany
2   Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
03 August 2015 (online)

    Permissions and Reprints

Abstract

Chronic obstructive pulmonary disease (COPD) is a widespread disease associated with high morbidity and mortality. The principal aim of therapy is preventing disease progression. Besides rehabilitation and pharmacological treatment, different endoscopic approaches were developed in the past decade extending the therapeutic spectrum. Various endoscopic lung volume reduction (ELVR) techniques are available that differ in the implementation, mechanism of action, complication spectrum, and reversibility. So far, the data on efficacy and safety are variable and still very limited. The most comprehensive data are available for endoscopic valve therapy. This reversible technique leads to lobar atelectasis and thus significant lobar volume reduction in patients with severe emphysema and low collateral ventilation. Implantation of coils leading to parenchymal compression and bronchoscopic thermal vapor ablation inducing an inflammatory reaction are nonblocking ELVR techniques and thus independent of collateral ventilation. Besides ELVR techniques, targeted lung denervation has evolved as the latest development in the field of endoscopic therapy in COPD. The aim of this endoscopic method is sustainable bronchodilation by minimizing the influence of parasympathetic pulmonary nerves on smooth muscles of the airways. This review summarizes the different endoscopic procedures, their mechanism of action, and the results of the clinical trials including efficacy and safety.

Keywords

endoscopic lung volume reduction - endoscopic valve therapy - thermal vapor ablation - collateral ventilation - emphysema - targeted lung denervation
 

  • References

  • 1 Gillissen AET. Weißbuch Lunge 2014. Herausforderungen, Zukunftsperspektiven, Forschungsansätze. Zur Lage und Zukunft der Pneumologie in Deutschland. Herne, Westf. FRISCHTEXTE Verlag; 2014
    Google Scholar
  • 2 Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013; 369 (5) 448-457
    CrossrefPubMedGoogle Scholar
  • 3 Global Strategy for the Diagnosis, Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2015
    PubMed
  • 4 Fishman A, Martinez F, Naunheim K , et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348 (21) 2059-2073
    CrossrefPubMedGoogle Scholar
  • 5 Toma TP, Hopkinson NS, Hillier J , et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361 (9361) 931-933
    CrossrefPubMedGoogle Scholar
  • 6 Snell GI, Holsworth L, Borrill ZL , et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 2003; 124 (3) 1073-1080
    CrossrefPubMedGoogle Scholar
  • 7 Sciurba FC, Ernst A, Herth FJF , et al; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363 (13) 1233-1244
    CrossrefPubMedGoogle Scholar
  • 8 Herth FJ, Noppen M, Valipour A , et al; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39 (6) 1334-1342
    CrossrefPubMedGoogle Scholar
  • 9 Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJF. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration 2010; 80 (5) 419-425
    CrossrefPubMedGoogle Scholar
  • 10 Herth FJ, Eberhardt R, Gompelmann D , et al. Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J 2013; 41 (2) 302-308
    CrossrefPubMedGoogle Scholar
  • 11 Gompelmann D, Eberhardt R, Slebos DJ , et al. Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology 2014; 19 (4) 524-530
    CrossrefPubMedGoogle Scholar
  • 12 Ninane V, Geltner C, Bezzi M , et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J 2012; 39 (6) 1319-1325
    CrossrefPubMedGoogle Scholar
  • 13 Eberhardt R, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012; 142 (4) 900-908
    CrossrefPubMedGoogle Scholar
  • 14 Gompelmann D, Herth FJF, Heussel CP, Hoffmann H, Dienemann H, Eberhardt R. Pneumothorax nach endoskopischer Ventiltherapie. Pneumologie 2014; 68 (S1): V454
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Gompelmann D, Herth FJF, Slebos DJ , et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014; 87 (6) 485-491
    CrossrefPubMedGoogle Scholar
  • 16 Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010; 4 (4) 225-231
    CrossrefPubMedGoogle Scholar
  • 17 Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142 (3) 574-582
    CrossrefPubMedGoogle Scholar
  • 18 Shah PL, Zoumot Z, Singh S , et al; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013; 1 (3) 233-240
    CrossrefPubMedGoogle Scholar
  • 19 Deslee G, Klooster K, Hetzel M , et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax 2014; 69 (11) 980-986
    CrossrefPubMedGoogle Scholar
  • 20 Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration 2014; 88 (2) 116-125
    CrossrefPubMedGoogle Scholar
  • 21 Kontogianni K, Gerovasili V, Gompelmann D , et al. Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: a six-month follow-up. Respiration 2014; 88 (1) 52-60
    CrossrefPubMedGoogle Scholar
  • 22 Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg 2009; 88 (6) 1993-1998
    CrossrefPubMedGoogle Scholar
  • 23 Herth FJF, Eberhardt R, Ernst A , et al. The efficacy of bronchoscopic thermal vapor ablation in patients with upper lobe emphysema: the impact of heterogeneity of disease. Abstract 5167. ATS 2010; 5167
    PubMedGoogle Scholar
  • 24 Snell G, Herth FJ, Hopkins P , et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012; 39 (6) 1326-1333
    CrossrefPubMedGoogle Scholar
  • 25 Emery MJ, Eveland RL, Eveland K, Couetil LL, Hildebrandt J, Swenson ER. Lung volume reduction by bronchoscopic administration of steam. Am J Respir Crit Care Med 2010; 182 (10) 1282-1291
    CrossrefPubMedGoogle Scholar
  • 26 Herth FJ, Ernst A, Baker KM , et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis 2012; 7: 397-405
    PubMedGoogle Scholar
  • 27 Gompelmann D, Eberhardt R, Ernst A , et al. The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013; 86 (4) 324-331
    CrossrefPubMedGoogle Scholar
  • 28 Gompelmann D, Heussel CP, Eberhardt R , et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respiration 2012; 83 (5) 400-406
    CrossrefPubMedGoogle Scholar
  • 29 Valipour A, Pison C, Kessler R, Deslee G. Bilateral targeted lung denervation in patients with COPD in a single procedure. Abstract 1775; ERS 2014
    PubMedGoogle Scholar
  • 30 Slebos DJ, Klooster K, Koegelenberg C , et al. Efficacy of targeted lung denervation in patients with moderate to severe COPD. Abstract 1774; ERS 2014
    PubMedGoogle Scholar